Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Obaid S Shaikh

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Gastroenterology Research|October 28, 2016
Hepatitis C in Liver Allograft Recipients: Utility of One-Year Post-Transplantation Biopsy as an Indicator of Antiviral TherapyShahid Habib, Shahid Malik, Bo Fu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 24, 2018
Trends in Treatment Uptake and Provider Specialty for Hepatitis C Virus (HCV) Infection in the Veterans Affairs Healthcare System: Results From the Electronically Retrieved Cohort of HCV-Infected Veterans (ERCHIVES)Adeel A Butt, Peng Yan, Vincent Lo Re Iii, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 5, 2022
Relative Vaccine Effectiveness of a Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccine Booster Dose Against the Omicron VariantAdeel A Butt, Victor B Talisa, Obaid S Shaikh, et al.
Gastroenterology Research|October 28, 2016
Slower Fibrosis Progression Among Liver Transplant Recipients With Sustained Virological Response After Hepatitis C TreatmentShahid Habib, Edward Meister, Sana Habib, et al.
The Journal of Infection|May 30, 2021
Rate and risk factors for breakthrough SARS-CoV-2 infection after vaccinationAdeel A Butt, Tasnim Khan, Peng Yan, et al.
Lancet Regional Health. Americas|February 24, 2026
Hepatitis C and risk of tuberculosis amongst United States veterans: a national cohort studyAmyn A Malik, Peng Yan, Sameer M Belgaumi, et al.
Open Forum Infectious Diseases|July 26, 2022
Comparative COVID-19 Vaccine Effectiveness Over Time in VeteransFlorian B Mayr, Victor B Talisa, Obaid S Shaikh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 17, 2019
Liver Fibrosis Progression and Mortality in Hepatitis B- and C-Coinfected Persons Treated With Directly Acting Antiviral Agents: Results From ERCHIVESAdeel A Butt, Peng Yan, Samia Aslam, et al.
Gastroenterology|November 17, 2018
Direct-Acting Antiviral Therapy for HCV Infection Is Associated With a Reduced Risk of Cardiovascular Disease EventsAdeel A Butt, Peng Yan, Ashfaq Shuaib, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 4, 2022
Vaccine Effectiveness of 3 Versus 2 Doses of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccines in a High-Risk National PopulationAdeel A Butt, Victor B Talisa, Peng Yan, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Gastroenterology Research|October 28, 2016
Hepatitis C in Liver Allograft Recipients: Utility of One-Year Post-Transplantation Biopsy as an Indicator of Antiviral TherapyShahid Habib, Shahid Malik, Bo Fu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 24, 2018
Trends in Treatment Uptake and Provider Specialty for Hepatitis C Virus (HCV) Infection in the Veterans Affairs Healthcare System: Results From the Electronically Retrieved Cohort of HCV-Infected Veterans (ERCHIVES)Adeel A Butt, Peng Yan, Vincent Lo Re Iii, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 5, 2022
Relative Vaccine Effectiveness of a Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccine Booster Dose Against the Omicron VariantAdeel A Butt, Victor B Talisa, Obaid S Shaikh, et al.
Gastroenterology Research|October 28, 2016
Slower Fibrosis Progression Among Liver Transplant Recipients With Sustained Virological Response After Hepatitis C TreatmentShahid Habib, Edward Meister, Sana Habib, et al.
The Journal of Infection|May 30, 2021
Rate and risk factors for breakthrough SARS-CoV-2 infection after vaccinationAdeel A Butt, Tasnim Khan, Peng Yan, et al.
Lancet Regional Health. Americas|February 24, 2026
Hepatitis C and risk of tuberculosis amongst United States veterans: a national cohort studyAmyn A Malik, Peng Yan, Sameer M Belgaumi, et al.
Open Forum Infectious Diseases|July 26, 2022
Comparative COVID-19 Vaccine Effectiveness Over Time in VeteransFlorian B Mayr, Victor B Talisa, Obaid S Shaikh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 17, 2019
Liver Fibrosis Progression and Mortality in Hepatitis B- and C-Coinfected Persons Treated With Directly Acting Antiviral Agents: Results From ERCHIVESAdeel A Butt, Peng Yan, Samia Aslam, et al.
Gastroenterology|November 17, 2018
Direct-Acting Antiviral Therapy for HCV Infection Is Associated With a Reduced Risk of Cardiovascular Disease EventsAdeel A Butt, Peng Yan, Ashfaq Shuaib, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 4, 2022
Vaccine Effectiveness of 3 Versus 2 Doses of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccines in a High-Risk National PopulationAdeel A Butt, Victor B Talisa, Peng Yan, et al.
Pageof 5